Statistics for Ascendis Pharma A/S (id:7370 ASND)

Valuation metrics

Market cap

7.63B

Enterprise value

8.26B

Trailing P/E (ttm)

-14.55

Forward P/E

-32.32

PEG ratio

-32.32

Price/Sales (ttm)

24.02

Price/Book (mrq)

-22.21

Enterprise Value/Revenue

24.49

Enterprise Value/EBITDA

-22.40

Overview

Shares outstanding

59.76M

Float

56.93M

Shares short

3.23M

% Held by insiders

0.01%

% Held by institutions

1.05%

Average volume (10 days)

377.06K

Average volume (90 days)

Price summary

52-Week low

90.13

52-Week high

161.00

52-Week change

25.84%

Beta

0.65

50-Day moving average

132.05

200-Day moving average

137.26

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-154.12%

Operating margin

-370.18%

Operational effectiveness

Return on assets

-27.92%

Return on equity

330.44%

Income statement

Revenue (ttm)

5.60

Revenue per share (ttm)

5.60

Quarterly revenue growth (yoy)

Gross profit (ttm)

236.12M

EBITDA

-368,743,261.00

Net income to common (ttm)

-519,900,258.00

Diluted EPS (ttm)

-9.24

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

274.75M

Total cash per share (mrq)

4.51

Total debt (mrq)

714.39M

Total Debt/Equity (mrq)

-2.09

Current ratio (mrq)

74.00%

Book value per share (mrq)

-5.60

Cash flow

Cash flow statement

-350,567,012.00

Levered free cash flow (LFCF)

-110,591,751.00